# Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

> **NCT04486625** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 11 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** Aztreonam-Avibactam
- **DRUG:** Aztreonam-Avibactam

## Key facts

- **NCT ID:** NCT04486625
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-10
- **Primary completion:** 2021-09-20
- **Final completion:** 2021-10-18
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486625, "Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04486625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*